- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT02206906
Incentives to Promote Medication Adherence Among HIV-Infected Youth
Investigation of Incentives to Promote Medication Adherence Among HIV-Infected Youth on Antiretroviral Therapy
연구 개요
상세 설명
PRIMARY OBJECTIVE:
- To describe the effects of a novel incentive intervention model on HIV-infected youths' patterns of antiretroviral medication adherence.
SECONDARY OBJECTIVES:
- To evaluate the feasibility of an outpatient incentive intervention model.
- To assess participant satisfaction with the incentive intervention model.
- To evaluate the effect of an outpatient incentive intervention model on targeted health behaviors (numbers of missed appointments and STI diagnoses).
- To measure the effect of the incentive intervention on HIV viral load and CD4+ count.
- To determine the overall and per patient cost of the incentive intervention model.
- To describe associations between adherence measures: real-time medication monitor data, pharmacy pill count, pharmacy prescription pick-up data, medication possession ratio, and self-report.
Upon enrollment, participants will receive education and a real-time medication monitor. Participants will be followed monthly in the clinic and will be prescribed thirty-day supplies of medication. During weeks 1-4 participants will establish a baseline with the real-time medication monitor. During weeks 5-28, participants will receive remote incentives based on their level of medication adherence as measured by the real-time medication monitor. Additional lottery-style incentives will occur at regular follow-up visits. No incentives will be applied during weeks 29-48. Participants will complete the protocol at the week 48 visit.
연구 유형
등록 (실제)
연락처 및 위치
연구 장소
-
-
Tennessee
-
Memphis, Tennessee, 미국, 38105
- St. Jude Children's Research Hospital
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
설명
Inclusion Criteria:
- ≥16 and ≤ 24 years old
- Documented diagnosis of HIV
- Adolescent is aware of his/her HIV diagnosis
- Adolescent understands either written or spoken English.
- Adolescent is willing and able to provide informed consent or assent.
- Adolescent has access to a phone and the internet at the time of enrollment.
Adolescent meets the definition of inadequate ARV adherence, which is any of the following in the previous 12 months:
- < 80% adherent to any ARV by pharmacy pill count
- ≥ 7 days delay in scheduled ARV prescription pick-up
- Detectable viral load after being on ARVs for at least 12 weeks
Exclusion Criteria:
- Adolescent has a documented diagnosis of mental retardation or a significant motor or sensory impairment that would preclude participation.
- Adolescent has a documented acute psychiatric illness, including suicidal ideation, homicidal ideation or active psychosis.
- Adolescent was diagnosed with HIV in the previous 6 months.
- Adolescent has a planned transition to alternative care setting prior to study completion (e.g. relocation, pregnancy or planned pregnancy, transition to adult care).
- Concurrent enrollment on a research study with an intervention targeted at increasing adherence to antiretroviral regimens.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: 보병대
- 시간 관점: 유망한
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
---|---|
Study Participants
All participants who meet eligibility requirements and who consent to participation will use an incentive intervention model.
|
All participants will receive a real-time electronic medication monitor to monitor daily pill-taking behavior.
Participants with qualifying levels of adherence will receive a weekly incentive during the intervention period.
At all clinic visits participants will participate in a lottery incentive to reinforce clinic attendance and negative STI screening tests.
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Percentage of dosages taken within 2 hours of prescribed time per month
기간: Monthly through week 48
|
Data collected by a real-time medication monitor that records pillbox opening times.
|
Monthly through week 48
|
Pharmacy pill count
기간: Monthly from 6 months prior to study start through week 48
|
Pharmacy pill count data is collected at each participant encounter, approximately once per month.
|
Monthly from 6 months prior to study start through week 48
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Feasibility - Accrual percentage
기간: End of study (week 48)
|
Number of people enrolled in study/number approached for enrollment.
|
End of study (week 48)
|
Feasibility - Drop out rate
기간: End of study (week 48)
|
Number of people ending protocol early/ total enrollment
|
End of study (week 48)
|
Feasibility - Participant reported device concerns
기간: End of study (week 48)
|
Problems with the Wisepill devices as spontaneously reported by participants or as assessed at routine follow-up.
|
End of study (week 48)
|
Feasibility - Device replacement rate
기간: End of study (week 48)
|
Number of devices requiring replacement due to loss/theft/breakage
|
End of study (week 48)
|
Feasibility - Contact failure rate
기간: End of study (week 48)
|
Number of failed attempts to contact participants/total number of contact attempts made
|
End of study (week 48)
|
Feasibility - Staff hours per week
기간: End of study (week 48)
|
Hours spent providing remote incentives
|
End of study (week 48)
|
Feasibility - Adverse effects of incentives
기간: End of study (week 48)
|
Unexpected risks/harms of providing incentives as self-reported by participants.
|
End of study (week 48)
|
Percentage of participants who are satisfied with the incentive intervention
기간: Enrollment (week 0) and end of study (week 48)
|
To assess participant satisfaction with the incentive intervention model.
Patient satisfaction, assessed by ACASI survey, will be summarized and tabulated for baseline (week 0) and follow-up (week 48) measurements.
|
Enrollment (week 0) and end of study (week 48)
|
Effect of incentives on missed appointment rate
기간: Enrollment (week 0) and end of study (week 48)
|
Descriptive statistics of numbers of missed appointments such as mean, interquartile range and median, during each study phase will be computed and compared
|
Enrollment (week 0) and end of study (week 48)
|
Effect of incentives on STI rates
기간: Enrollment (week 0) and end of study (week 48)
|
Descriptive statistics of numbers of STI rates such as mean, interquartile range and median, during each study phase will be computed and compared
|
Enrollment (week 0) and end of study (week 48)
|
Change in biological parameters
기간: At weeks 0, 12, 24, 36 and 48
|
To measure the effect of the incentive intervention on HIV viral load and CD4+ count.
HIV viral load and CD4+ count measured at week 0, 12, 24, 36 and 48 will be summarized and plotted by descriptive statistics, such as mean and standard deviation.
Mixed effects models will be applied to explore the effect of the intervention on HIV viral load and CD4+ count.
|
At weeks 0, 12, 24, 36 and 48
|
Overall cost of incentive intervention
기간: End of study (week 48)
|
To determine the overall and per patient cost of the incentive intervention model the accumulated overall and per patient cost till week 48 will be summarized and tabulated.
|
End of study (week 48)
|
Association between adherence measures
기간: End of study (week 48)
|
To describe associations between adherence measures: Wisepill data, pharmacy pill count, pharmacy prescription pick-up data, medication possession ratio, and self-report.
Associations of Wisepill adherence rates with pill count and pick up rates will be described by Pearson or Spearman's correlation coefficients and intraclass correlation coefficients as appropriate.
|
End of study (week 48)
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Ronald Dallas, PhD, St. Jude Children's Research Hospital
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (추정)
연구 기록 업데이트
마지막 업데이트 게시됨 (추정)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
기타 연구 ID 번호
- INMED
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
에이즈에 대한 임상 시험
-
Hospital Clinic of Barcelona완전한
-
French National Agency for Research on AIDS and...Elizabeth Glaser Pediatric AIDS Foundation완전한파트너 HIV 테스트 | 부부 에이즈 상담 | 커플커뮤니케이션 | HIV 발병률카메룬, 도미니카 공화국, 그루지야, 인도
-
University of Minnesota빼는HIV 감염 | HIV/에이즈 | 에이즈 | 보조기구 | 에이즈/HIV 문제 | 에이즈와 감염미국
-
Michael HoelscherClinton Health Access Initiative Inc.; Instituto Nacional de Saúde (INS), Ministério da... 그리고 다른 협력자들모집하지 않고 적극적으로HIV, 신생아 HIV 조기 진단(EID), 현장 진료 검사(PoC)모잠비크, 탄자니아
-
National Institute of Allergy and Infectious Diseases...Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)완전한
-
Erasmus Medical Center모병
-
Allegheny Singer Research Institute (also known...모집하지 않고 적극적으로
-
Erasmus Medical Center아직 모집하지 않음
-
University of Maryland, BaltimoreNational Institute of Mental Health (NIMH); Albert Einstein College of Medicine; Yale University 그리고 다른 협력자들아직 모집하지 않음HIV 예방 | HIV 사전 노출 예방
-
Erasmus Medical Center모집하지 않고 적극적으로
Incentive intervention model에 대한 임상 시험
-
Charles G. ProberStanford University; Heidelberg University; University of Stellenbosch; University of Cape...완전한
-
University Hospital, Montpellier종료됨
-
Chinese University of Hong KongNational Institutes of Health (NIH)완전한
-
Hsin-Wen HsuKaohsiung Medical University Chung-Ho Memorial Hospital완전한
-
Bausch & Lomb Incorporated모병
-
VA Office of Research and Development모집하지 않고 적극적으로
-
Washington University School of MedicineSt. Jude Children's Research Hospital완전한